Affimed N.V.
AFMD · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $155 | $154 | $155 | $413 |
| % Growth | 0.6% | -0.6% | -62.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $155 | $154 | $155 | $413 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $10,136 | $11,727 | $15,391 | $18,656 |
| G&A Expenses | $4,311 | $4,036 | $4,476 | $6,168 |
| SG&A Expenses | $4,311 | $4,036 | $4,476 | $6,168 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$9 | -$56 | $177 | $0 |
| Operating Expenses | $14,438 | $15,707 | $19,867 | $24,604 |
| Operating Income | -$14,283 | -$15,553 | -$19,535 | -$20,835 |
| % Margin | -9,214.8% | -10,099.4% | -12,603.2% | -5,044.8% |
| Other Income/Exp. Net | -$855 | $105 | $360 | $630 |
| Pre-Tax Income | -$15,138 | -$15,448 | -$19,175 | -$20,205 |
| Tax Expense | $1 | $3 | $0 | $0 |
| Net Income | -$15,139 | -$15,451 | -$19,175 | -$20,205 |
| % Margin | -9,767.1% | -10,033.1% | -12,371% | -4,892.3% |
| EPS | -0.94 | -1.01 | -1.27 | -1.35 |
| % Growth | 6.9% | 20.5% | 5.9% | – |
| EPS Diluted | -0.94 | -1.01 | -1.27 | -1.35 |
| Weighted Avg Shares Out | 16,100 | 15,301 | 15,130 | 14,940 |
| Weighted Avg Shares Out Dil | 16,100 | 15,301 | 15,130 | 14,940 |
| Supplemental Information | – | – | – | – |
| Interest Income | $228 | $306 | $367 | $371 |
| Interest Expense | $267 | $316 | $363 | $412 |
| Depreciation & Amortization | $425 | $430 | $2,090 | $476 |
| EBITDA | -$14,446 | -$14,702 | -$16,722 | -$19,317 |
| % Margin | -9,320% | -9,546.8% | -10,788.4% | -4,677.2% |